Remove a protein that releases stored fat, and the textbook prediction is clear: the fat stays. Mice without it should become obese. People without it should too. That is what the model of hormone-sensitive lipase has said for sixty years. It's wrong.
The Anomaly in the Knockout Mice
Hormone-sensitive lipase is an enzyme. Its established function is to hydrolyze triglycerides stored in fat cells, releasing fatty acids into the bloodstream when the body needs fuel. When you exercise, when you fast, when adrenaline signals your system that energy is required, HSL activates. It breaks down stored fat. That's what it does. Or so scientists believed for six decades.
The problem showed up in the knockout experiments. When researchers bred mice with the HSL gene disabled, the expected result was fat accumulation: animals that couldn't release their stored energy, gaining weight as their fat cells filled up. What actually happened was the opposite. The mice lost fat tissue. Their adipocytes, the cells that store fat, deteriorated. The animals developed lipodystrophy: a condition where fat tissue fails to form or is progressively lost, leaving the body without the metabolic buffer that fat tissue provides.
This is not a minor discrepancy. If HSL's only job is to release fat, then losing HSL should trap fat in place, not destroy the tissue holding it. The anomaly sat in the literature for years, unexplained, a data point that didn't fit the model.
Inside the Nucleus of the Fat Cell
The team led by Dominique Langin went looking for HSL with better tools than the field had previously used. Advanced imaging. Subcellular fractionation, a technique that physically separates a cell's compartments so you can inventory the contents of each one. Protein-protein interaction assays that reveal what a molecule is binding to inside the cell.
They found HSL in the nucleus of adipocytes. Not just at the nuclear membrane, not in transit. Actually inside the nucleus, interacting with nuclear proteins, positioned where gene regulation happens. HSL was bound to chromatin-associated proteins and participating in the maintenance of the adipocyte transcriptional program: the gene expression pattern that keeps a fat cell functioning as a fat cell.
Fat tissue is not merely storage. It's an endocrine organ that produces leptin (the hormone that signals satiety), adiponectin (which regulates insulin sensitivity), and a range of cytokines that coordinate metabolic function. Without adequate fat tissue, the body loses these signals. Lipodystrophy patients typically develop severe insulin resistance, high triglycerides, and fatty liver disease — conditions more associated with obesity in the public mind, but which arise here from the opposite cause. The metabolic syndrome of obesity and the metabolic syndrome of lipodystrophy look remarkably similar.
The nuclear function of HSL explains what the knockout experiments were actually showing. Mice and people without HSL don't just lose the ability to release fat. They lose the program that keeps their fat cells alive and differentiated. The nucleus role of HSL isn't a redundant backup; it's the mechanism that maintains fat tissue integrity. When it's absent, the fat tissue doesn't persist. It fails.
What Sixty Years of Certainty Missed
The textbook model of HSL isn't wrong, exactly. It's incomplete. HSL does hydrolyze stored triglycerides. That function is real and well-documented. What sixty years of research missed is that the same molecule also does something structurally different, in a different part of the cell, with different binding partners, serving a different biological purpose. That kind of dual function, sometimes called "moonlighting," turns out to be more common in biology than classical biochemistry anticipated. Enzymes were originally conceptualized as highly specific machines: one substrate, one reaction, one role. The reality is messier and more interesting.
| Aspect | Old Model | New Understanding |
|---|---|---|
| Location in cell | Cytoplasm, lipid droplet surface | Cytoplasm AND nucleus |
| Primary function | Hydrolyze stored triglycerides | Triglyceride hydrolysis + nuclear gene regulation |
| Binding partners | Lipid droplet proteins (perilipin) | Lipid droplet proteins + chromatin-associated nuclear proteins |
| Loss-of-function result | Predicted: fat accumulation | Actual: fat tissue loss (lipodystrophy) |
| Metabolic role | Acute energy mobilization | Acute energy mobilization + long-term adipocyte maintenance |
Figure 1 — HSL: old model vs. 2026 findings (Langin et al., Cell Metabolism)
The technique that made the discovery possible — subcellular fractionation combined with modern protein interaction assays — was available for years. What changed was the resolution and the willingness to look. The nucleus is not where you expect a lipase to be. Most researchers studying HSL were asking questions about lipid metabolism, not gene regulation. The tools for one set of questions don't necessarily reveal the answers hiding in another domain.
The New Questions at the Fat Cell's Core
The immediate clinical implication is for the small population of patients with HSL mutations who develop lipodystrophy. Understanding why the fat tissue fails — because of a nuclear function, not just the loss of fat mobilization — changes the therapeutic logic entirely. A drug that compensates for lost triglyceride hydrolysis won't help these patients. What they need is something that restores adipocyte maintenance. That's a different target.
The broader implication is for obesity research. HSL sits at what was thought to be a known node in fat metabolism. The discovery that it has a second, structurally distinct job suggests the node is more complex than the models captured. Other proteins in the adipocyte's metabolic machinery may have undiscovered nuclear functions. The toolset for finding them exists. Langin's team has shown it works.
There's a quieter implication too. Sixty years is a long time for an incomplete picture to persist. The HSL story isn't a case of bad science or fraud. The original characterization of HSL as a fat-releasing enzyme was careful, accurate, and reproducible. It just wasn't the whole answer. The anomaly in the knockout data was visible for years. It took new tools and the right question to explain it.
Biology has a great many proteins whose full story hasn't been told yet. This finding is a reminder that "well-characterized" and "fully understood" are not the same thing. The nucleus of the fat cell, it turns out, has been busier than anyone realized.
Buy me a coffee